跳至主要内容
临床试验/NCT01488539
NCT01488539已完成不适用

Implementation of an Evidence Based PTSD Treatment in Public Sector Settings

Palo Alto Veterans Institute for Research9 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
210
试验地点
9
主要终点
Clinician Assessed PTSD Symptom Severity

研究概览

简要总结

Researchers hope to learn whether a flexibly applied cognitive behavioral treatment for Post-Traumatic Stress Disorder (PTSD) is more effective than the psychotherapy usually provided in the clinic (called Treatment as Usual or TAU). Primary Hypothesis: STAIR/NT will be superior to TAU in improving PTSD symptoms at 28, 36 and 48 weeks post-randomization

详细描述

PTSD among women is a particularly pernicious and chronic disorder associated with significant psychiatric comorbidity, high rates of suicidality, substance abuse, self-injury and multiple traumatization including repeated sexual assault and domestic violence. Public-sector mental health services are the disproportionate recipient of traumatized women with between 62% to 98% of treatment seeking women reporting a history of trauma and of those, up to 40% carry a diagnosis of PTSD with various comorbidities. Over 40 single-site randomized trials of cognitive-behavioral therapy for PTSD have been conducted. However, to date, there are only two large-sample randomized clinical trials which have evaluated the effectiveness of such treatments in the community and both of them concerned military populations. This application proposes to evaluate the effectiveness of an evidence-based PTSD treatment in the context of a collaborative partnership of four public mental health clinics serving diverse populations. The intervention is a two module, sequential treatment (STAIR/NT) in which the first module emphasizes present-focused skills training in affective and interpersonal regulation (STAIR) for day-to-day life difficulties and the second module incorporates past-focused work on the processing of the trauma, using narrative therapy (NT). This cognitive behavioral treatment was specifically designed to treat high risk, multiply traumatized women with chronic PTSD and has been demonstrated to provide significant and clinically substantial relief from PTSD as well as improvement in emotion management and interpersonal functioning.

The investigators will assess the effectiveness of STAIR/NT compared to Treatment as Usual (TAU) in the context of every day clinical care. The study is a randomized, controlled repeated measures intent-to-treat design to assess STAIR/NT as compared to TAU at post-treatment and three and six-month follow-up. Four sites (Western Ontario, Boston, New York and Atlanta), each situated within a large public sector mental health network, will enroll 88 treatment-seeking women with PTSD related to interpersonal violence yielding a total of 352 study participants. The primary outcome will be PTSD symptom severity. Secondary outcomes will be negative mood regulation self-efficacy, interpersonal problems and general level of psychiatric impairment (GAF scores). Exploratory aims include the examination of the relationship between variations in treatment implementation and treatment outcome as well as the influence of patient characteristics and other contextual (therapist and organization) variables likely to impact implementation. The investigators will also introduce web-based technology as a resource intended to strengthen clinical networks and maintain use of study materials after the trial has ended.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A primary diagnosis of PTSD according to DSM-IV criteria with a CAPS score no lower than 40 (cf Weathers, Keane, & Davidson, 2001)
  • PTSD symptoms that are a result of interpersonal violence
  • at least one clear trauma memory
  • Current age between 18 and 65
  • If obtaining other (medication or psychosocial) treatment, must have completed at least a 3 month course of the treatment

排除标准

  • Substance dependence and severe substance abuse disorders, current psychotic symptoms, unmedicated mania or bipolar disorder
  • prominent current suicidal or homicidal ideation (a plan or intent versus a wish) or a suicide attempt within the past three months
  • self-injurious behaviors in the last three months requiring medical attention
  • Cognitive impairment indicated by chart diagnoses or observable cognitive difficulties
  • Current involvement in a violent relationship defined as more than casual contact (e.g. dating or living with an abusive partner)

结局指标

主要结局

Clinician Assessed PTSD Symptom Severity

时间窗: Baseline, 28, 36, 48 weeks

Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) includes 20 items rated on a 5 point scale from 0 to 4. Possible total scores range from 0 to 80, with higher scores indicating more severe PTSD.

PTSD Diagnosis

时间窗: Baseline, 28, 36, 48 weeks

Clinician Adminstered PTSD Scale for DSM-5 (CAPS-5) assess the presence of PTSD diagnosis following the requirements indicated by DSM-5. These include the presence of 5 symtpom clusters that include re-experiencing symptoms, avoidance symptoms, alterations in mood and cognitions and hyperarousal.

次要结局

  • Emotion Regulation Problems(Baseline, 12, 28, 36, 48 weeks)
  • Interpersonal problems(Baseline, 12, 28, 36, 48 weeks)
  • Psychosocial Functioning(Baseline, 28, 36, 48 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marylène Cloitre

Research Health Science Specialist

Palo Alto Veterans Institute for Research

研究点 (9)

Loading locations...

相似试验

Implementation of an Evidence Based Post-Traumatic... | 临床试验